At UCT Frankfurt, there is a complete clinical data collection from all patients who have been first diagnosed since 2012 and have been treated at the UCT (around 10,000 patients).
Biomaterials are available from patients whose tumor material has been studied in the pathology department. Moreover, there is fresh frozen material from more than 8,000 patients. The bone marrow biobank in which vitally frozen bone marrow of leukemia patients is stored is also connected to FCI. Since 2016, the Georg-Speyer-Haus has been involved in the establishment of an organoid biobank of patients with colorectal carcinoma (see Research Area 3). A central access system and a project management team enable scientists to use these resources efficiently through the Clinical Communication Platform.
In addition, the Oncology Coordination Center for Clinical Trials (O-KKS) at UCT has a central unit that supports the FCI with all aspects of self-initiated studies. There is extensive experience in the coordination of academic studies of all phases; in a Phase I / II study unit, specialized staff carry out complex study therapies, including first-in-man studies.